ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 70 filers reported holding ODONATE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $925,000 | -2.2% | 700,421 | 0.0% | 0.23% | +26.6% |
| Q4 2021 | $946,000 | -53.6% | 700,421 | 0.0% | 0.18% | -42.5% |
| Q3 2021 | $2,038,000 | -16.6% | 700,421 | 0.0% | 0.32% | +6.0% |
| Q2 2021 | $2,444,000 | +2.0% | 700,421 | 0.0% | 0.30% | -31.7% |
| Q1 2021 | $2,395,000 | -84.7% | 700,421 | -14.1% | 0.44% | -71.9% |
| Q4 2020 | $15,656,000 | +43.0% | 815,421 | 0.0% | 1.57% | -48.5% |
| Q3 2020 | $10,951,000 | -47.9% | 815,421 | +64.2% | 3.06% | -54.8% |
| Q2 2020 | $21,022,000 | +45.7% | 496,505 | -5.0% | 6.76% | -18.6% |
| Q1 2020 | $14,430,000 | -14.9% | 522,637 | 0.0% | 8.30% | +2.2% |
| Q4 2019 | $16,960,000 | +24.7% | 522,637 | 0.0% | 8.13% | -12.2% |
| Q3 2019 | $13,604,000 | -39.8% | 522,637 | -15.1% | 9.26% | -38.0% |
| Q2 2019 | $22,596,000 | +71.5% | 615,850 | +3.4% | 14.93% | +44.2% |
| Q1 2019 | $13,174,000 | +57.0% | 595,850 | 0.0% | 10.35% | +28.6% |
| Q4 2018 | $8,390,000 | – | 595,850 | – | 8.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|